Therapeutic evaluation of palbociclib and its compatibility with other chemotherapies for primary and recurrent nasopharyngeal carcinomaZhichao Xue(University of Hong Kong), Chi Man Tsang(Cancer Research Center)Journal of Experimental & Clinical Cancer ResearchNovember 26, 202010.1186/s13046-020-01763-zCited by 27SaveCiteExport RISWatch citationsRelated PapersBerberine suppresses tumorigenicity and growth of nasopharyngeal carcinoma cells by inhibiting STAT3 activation induced by tumor associated fibroblasts|BMC Cancer|2013|97ebv-sisRNA-3 contributes to the formation of G4-associated R-loop upstream of EBV lytic replication origin in latently infected cells|Cell & Bioscience|2025|0